Poland· PL-100197347
Rotarix
A rotavirus, lebend abgeschwächt product containing szczepionka przeciw rotawirusom, żywa, registered in Poland by GlaxoSmithKline Biologicals S.A.. The same ATC class is registered in 11 of our 19 countries.
Checked against URPL (Poland) on
Informational only — not a medical device.
Where it is registered
Rotavirus, lebend abgeschwächt is registered in 11 of 19 countries.
Countries holding a registration under ATC J07BH01 (rotavirus, lebend abgeschwächt), each read from that country’s own register.
- This record: Poland, from URPL (Poland)
- 7 of them publish a price we can compare per daily dose
Rotavirus, lebend abgeschwächt · ATC J07BH01
11 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Icelandprice
- Ireland
- Netherlands
- Norwayprice
- Polandprice
- Switzerlandprice
The record
At a glance
URPL (Poland)- Active substance
- Szczepionka przeciw rotawirusom, żywa
- Manufacturer
- GlaxoSmithKline Biologicals S.A.
- Country
- Poland (PL)
- ATC code
- J07BH01
- ATC class
- Rotavirus, lebend abgeschwächt
- Reimbursed
- Not published by this register
- Source register
- URPL (Poland)
- Last checked
- September 27, 2026
Packs & prices · 7
- gtin05909990657377
- gtin05909990657384
- gtin05909990657391
- gtin05909990657407
- gtin05909990657414
- gtin05909990657421
- gtin05909990657438
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same class
Other records under J07BH01
Rotavirus, lebend abgeschwächt, as other registers publish it.
- FinlandRotarixGlaxoSmithKline Biologicals SA
- DenmarkRotarixGlaxoSmithKline Biologicals
- NorwayRotarixGlaxoSmithKline Biologicals Services S.A
- BelgiumRotarixGlaxoSmithKline Biologicals
- FinlandRotarixGlaxoSmithKline Biologicals SA
- PolandRotarixGlaxoSmithKline Biologicals S.A.
- DenmarkRotarixGlaxoSmithKline Biologicals S.A.
- IcelandRotarixGlaxoSmithKline Biologicals S.A.*
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of URPL (Poland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/0ec08558-1125-4714-a33f-aa99009f321c GET /v1/drugs/0ec08558-1125-4714-a33f-aa99009f321c?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Zawiesina doustna",
"source": "urpl",
"strength": null,
"packaging": "05909990657377 ¦ Rp ¦ EU/1/05/330/005 ¦ 44905\n1 op. 1,5 ml\n05909990657384 ¦ Rp ¦ EU/1/05/330/006 ¦ 44906\n5 op. 1,5 ml\n05909990657391 ¦ Rp ¦ EU/1/05/330/007 ¦ 44907\n10 op. 1,5 ml\n05909990657407 ¦ Rp ¦ EU/1/05/330/008 ¦ 44908\n25 op. 1,5 ml\n05909990657414 ¦ Rp ¦ EU/1/05/330/009 ¦ 44909\n1 tubka 1,5 ml\n05909990657421 ¦ Rp ¦ EU/1/05/330/010 ¦ 44910\n10 tubek 1,5 ml\n05909990657438 ¦ Rp ¦ EU/1/05/330/011 ¦ 44911\n50 tubek 1,5 ml\nRp ¦ EU/1/05/330/012 ¦ 131712\n50 tubek 1,5 ml",
"substance": null,
"common_name": "Szczepionka przeciw rotawirusom, żywa",
"pl_product_id": "100197347",
"pozwolenie_nr": null,
"auth_procedure": "CEN",
"authorisation_validity": null
}See everything about rotavirus, lebend abgeschwächt.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.